• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical and serological evaluation of purified polysaccharide vaccines prepared from Neisseria meningitidis group Y.

作者信息

Farquhar J D, Hankins W A, DeSanctis A N, DeMeio J L, Metzgar D P

出版信息

Proc Soc Exp Biol Med. 1977 Sep;155(4):453-5. doi: 10.3181/00379727-155-39828.

DOI:10.3181/00379727-155-39828
PMID:408813
Abstract
摘要

相似文献

1
Clinical and serological evaluation of purified polysaccharide vaccines prepared from Neisseria meningitidis group Y.对从Y群脑膜炎奈瑟菌制备的纯化多糖疫苗的临床和血清学评估。
Proc Soc Exp Biol Med. 1977 Sep;155(4):453-5. doi: 10.3181/00379727-155-39828.
2
Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serological evaluation.
J Biol Stand. 1982 Oct;10(4):335-9. doi: 10.1016/s0092-1157(82)80010-3.
3
Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis.A群和C群脑膜炎奈瑟菌多糖疫苗对人类婴儿的免疫反应。
J Infect Dis. 1977 Aug;136 Suppl:S31-5. doi: 10.1093/infdis/136.supplement.s31.
4
Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, and Y.A群、C群和Y群脑膜炎球菌多糖疫苗的临床和血清学评估
Proc Soc Exp Biol Med. 1978 Jan;157(1):79-82. doi: 10.3181/00379727-157-39995.
5
Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.意大利新兵中A群和C群脑膜炎奈瑟菌荚膜多糖疫苗的血清抗体情况
Allergol Immunopathol (Madr). 1991 Jan-Feb;19(1):39-41.
6
Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135.A、C、Y和W135群脑膜炎球菌多糖疫苗的临床和血清学评估
Proc Soc Exp Biol Med. 1982 Jan;169(1):54-7. doi: 10.3181/00379727-169-41306.
7
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.B群脑膜炎奈瑟菌的荚膜多糖作为疫苗开发的载体。
Contrib Microbiol Immunol. 1989;10:151-65.
8
[Immunity against Neisseria meningitidis in different population groups].不同人群中针对脑膜炎奈瑟菌的免疫力
Rev Cubana Med Trop. 1989 Jan-Apr;41(1):135-47.
9
[Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].[接种纯化多糖疫苗作为预防流行性脑脊髓膜炎应急措施的效果调查]
Zhonghua Liu Xing Bing Xue Za Zhi. 1982 Dec;3(6):328-30.
10
Clinical and laboratory investigations of monovalent and combined meningococcal polysaccharide vaccine, groups A and C.A群和C群单价及联合脑膜炎球菌多糖疫苗的临床与实验室研究
Proc Soc Exp Biol Med. 1976 Dec;153(3):436-40. doi: 10.3181/00379727-153-39563.

引用本文的文献

1
Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults.成人中Y群和W135群脑膜炎球菌结合疫苗的安全性和免疫原性。
Infect Immun. 1981 Dec;34(3):725-32. doi: 10.1128/iai.34.3.725-732.1981.
2
Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens.脑膜炎奈瑟菌及分离的脑膜炎球菌表面抗原对小鼠B淋巴细胞的激活作用
Infect Immun. 1983 Nov;42(2):471-9. doi: 10.1128/iai.42.2.471-479.1983.
3
Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.
C群脑膜炎球菌多糖-破伤风类毒素结合物作为新一代疫苗的制备及免疫化学特性分析
Infect Immun. 1983 Apr;40(1):39-45. doi: 10.1128/iai.40.1.39-45.1983.
4
The meningococcus and mechanisms of pathogenicity.脑膜炎球菌与致病机制
Microbiol Rev. 1982 Jun;46(2):162-90. doi: 10.1128/mr.46.2.162-190.1982.